An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys)

Multicenter Cohort

Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China

World Journal of Pediatrics ◽

10.1007/s12519-019-00303-w ◽

2019 ◽

Vol 15 (6) ◽

pp. 595-600 ◽

Cited By ~ 3

Author(s):

Yao Hu ◽

Ying-Zi Ye ◽

Li-Jing Ye ◽

Xiao-Hong Wang ◽

Hui Yu

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Real Life ◽

Pegylated Interferon ◽

Efficacy And Safety ◽

Interferon Alpha 2B

Combination Therapy of Pegylated Interferon alpha 2b (PegIFN) and Adefovir Dipivoxil (ADV) in Chronic Hepatitis B (CH-B) Patients Reduces the Reservoir of Transcriptionally Active cccDNA and Hepatitis B Surface Antigen (HBsAg)

Zeitschrift für Gastroenterologie ◽

10.1055/s-2005-862299 ◽

2005 ◽

Vol 43 (01) ◽

Author(s):

F Metzler ◽

K Wursthorn ◽

B Zoellner ◽

P Buggisch ◽

M Zankel ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Adefovir Dipivoxil ◽

Hepatitis B Surface Antigen ◽

Pegylated Interferon ◽

Interferon Alpha 2B

Sa1313 Sequential Nuc Therapy Following Pegylated Interferon-Alpha Exposure Restores Innate Immune Responses Conferring a Treatment Advantage Over Nuc Monotherapy in Chronic Hepatitis B

Gastroenterology ◽

10.1016/s0016-5085(14)60915-x ◽

2014 ◽

Vol 146 (5) ◽

pp. S-260

Author(s):

Upkar S. Gill ◽

Dimitra Peppa ◽

Lorenzo Micco ◽

Harsimran D. Singh ◽

Graham Foster ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Immune Responses ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Innate Immune ◽

Innate Immune Responses ◽

Pegylated Interferon Alpha

ssHepatocellular carcinoma after treatment cessation in non‐cirrhotic HBeAg‐negative chronic hepatitis B: A multicenter cohort study

Liver International ◽

10.1111/liv.15128 ◽

2021 ◽

Author(s):

Margarita Papatheodoridi ◽

Tung‐Hung Su ◽

Emilia Hadziyannis ◽

Chun‐Hsun Liao ◽

Αfroditi Orfanidou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Treatment Cessation ◽

Multicenter Cohort ◽

Negative Chronic Hepatitis

Assessment of Quality of Life of Patients with Chronic Hepatitis B and C Treated with Pegylated Interferon-alpha

Viral Hepatitis Journal ◽

10.4274/vhd.2017.0016 ◽

2018 ◽

Vol 24 (2) ◽

pp. 25-42

Author(s):

Handan ALAY ◽

Kemalettin ÖZDEN ◽

Serpil EROL ◽

Neslihan ÇELİK ◽

Emine PARLAK ◽

...

Keyword(s):

Quality Of Life ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Pegylated Interferon Alpha

Combination therapy with peginterferonα-2a and adefovir dipivoxil for HBeAg-positive chronic hepatitis B: A prospective multicenter cohort study

World Chinese Journal of Digestology ◽

10.11569/wcjd.v20.i22.2036 ◽

2012 ◽

Vol 20 (22) ◽

pp. 2036

Author(s):

Yang Ding ◽

Fa-Ling Wu ◽

Qiu-Ju Sheng ◽

Lian-Rong Zhao ◽

Ting-Ting Xia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Multicenter Cohort ◽

Positive Chronic Hepatitis

51 Early hepatitis B viral dynamics and end of treatment virological response (ETVR) in chronic hepatitis B/ HBeAg (−) patients receiving 1528 0689V 2 pegylated interferon alpha-2b and/or lamivudine

Journal of Hepatology ◽

10.1016/s0168-8278(06)80516-7 ◽

2006 ◽

Vol 44 ◽

pp. S192

Author(s):

T. Vassiliadis ◽

V. Sypsa ◽

K. Mimidis ◽

N.C. Tassopoulos ◽

D. Chrysagis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Virological Response ◽

Pegylated Interferon ◽

Viral Dynamics ◽

Interferon Alpha 2B ◽

End Of Treatment

Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy

Molecular Medicine Reports ◽

10.3892/mmr.2014.2670 ◽

2014 ◽

Vol 11 (1) ◽

pp. 427-433

Author(s):

ZHELING WANG ◽

XIAOFEI LI ◽

CHANGHE SHI ◽

MIN ZHANG ◽

RU CHEN ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Hepatitis B Surface Antigen ◽

Pegylated Interferon ◽

Serum Biomarkers ◽

Interferon Alpha Therapy ◽

Alpha Therapy

19 ANTIVIRAL EFFECT OF ENTECAVIR: RESULTS FROM 160 CHRONIC HEPATITIS B PATIENTS IN AN INTERNATIONAL MULTICENTER COHORT STUDY

Journal of Hepatology ◽

10.1016/s0168-8278(09)60021-0 ◽

2009 ◽

Vol 50 ◽

pp. S10 ◽

Cited By ~ 1

Author(s):

J. Reijnders ◽

K. Deterding ◽

J. Petersen ◽

F. Zoulim ◽

T. Santantonio ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Antiviral Effect ◽

Multicenter Cohort ◽

International Multicenter

Add-on of pegylated interferon alpha–2a (PEG-IFN) triggers antigen-independent TNF-alpha production by CD4+ T cells in patients with pretreated chronic hepatitis B

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295894 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

T Bauer ◽

S Kutscher ◽

S Allgayer ◽

J Kittner ◽

M Schuchmann ◽

...

Keyword(s):

T Cells ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Cd4 T Cells ◽

Pegylated Interferon ◽

Tnf Alpha ◽

Alpha Production